Amedisys, Inc. (AMED)
USD 84.97
(-0.47%)
USD 84.97
(-0.47%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 216.91 Million USD | -15.42% |
| 2022 | 207.4 Million USD | -22.27% |
| 2021 | 320.65 Million USD | 12.24% |
| 2020 | 250.65 Million USD | 22.11% |
| 2019 | 203.35 Million USD | 34.02% |
| 2018 | 179.61 Million USD | 35.06% |
| 2017 | 128.28 Million USD | 46.4% |
| 2016 | 81.45 Million USD | -15.72% |
| 2015 | 88.13 Million USD | 77.83% |
| 2014 | 57.5 Million USD | 26.76% |
| 2013 | -112.19 Million USD | -50.01% |
| 2012 | -66.46 Million USD | 122.26% |
| 2011 | 294.72 Billion USD | -285.52% |
| 2010 | 229.37 Million USD | -11.49% |
| 2009 | 262.37 Million USD | 46.54% |
| 2008 | 178.38 Million USD | 67.24% |
| 2007 | 118 Million USD | 39.98% |
| 2006 | 76.21 Million USD | 33.87% |
| 2005 | 57.07 Million USD | 51.66% |
| 2004 | 37.5 Million USD | 122.02% |
| 2003 | 17.41 Million USD | -15.16% |
| 2002 | 11.06 Million USD | 87.93% |
| 2001 | 10.9 Million USD | 283.52% |
| 2000 | 308 Thousand USD | -89.03% |
| 1999 | 443 Thousand USD | 192.12% |
| 1998 | -23.9 Million USD | -4300.92% |
| 1997 | 652 Thousand USD | -68.78% |
| 1996 | 2.08 Million USD | 16.02% |
| 1995 | 1.8 Million USD | 260.0% |
| 1994 | 500 Thousand USD | 350.0% |
| 1993 | 100 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 58.42 Million USD | 34.86% |
| 2024 Q2 | 70.47 Million USD | 20.62% |
| 2023 FY | - USD | -15.42% |
| 2023 Q4 | 25.1 Million USD | -61.65% |
| 2023 Q1 | 56.54 Million USD | -11.09% |
| 2023 Q2 | 65.81 Million USD | 16.41% |
| 2023 Q3 | 65.46 Million USD | -0.53% |
| 2022 Q4 | 63.59 Million USD | 4.96% |
| 2022 Q2 | 67.25 Million USD | 3.45% |
| 2022 Q1 | 65 Million USD | -5.77% |
| 2022 Q3 | 60.58 Million USD | -9.91% |
| 2022 FY | - USD | -22.27% |
| 2021 Q4 | 68.98 Million USD | -10.02% |
| 2021 FY | - USD | 12.24% |
| 2021 Q1 | 87.68 Million USD | 0.33% |
| 2021 Q2 | 96.57 Million USD | 10.14% |
| 2021 Q3 | 76.67 Million USD | -20.61% |
| 2020 Q3 | 83.77 Million USD | 31.38% |
| 2020 Q4 | 87.39 Million USD | 4.32% |
| 2020 Q2 | 63.76 Million USD | 8.04% |
| 2020 Q1 | 59.01 Million USD | 0.42% |
| 2020 FY | - USD | 22.11% |
| 2019 Q1 | 57.04 Million USD | 37.41% |
| 2019 FY | - USD | 34.02% |
| 2019 Q2 | 63 Million USD | 10.46% |
| 2019 Q3 | 61.9 Million USD | -1.75% |
| 2019 Q4 | 58.77 Million USD | -5.06% |
| 2018 Q1 | 42.17 Million USD | 17.73% |
| 2018 Q2 | 49.4 Million USD | 17.12% |
| 2018 Q4 | 41.51 Million USD | -10.78% |
| 2018 Q3 | 46.52 Million USD | -5.82% |
| 2018 FY | - USD | 35.06% |
| 2017 Q4 | 35.82 Million USD | 21.26% |
| 2017 FY | - USD | 46.4% |
| 2017 Q1 | 30.6 Million USD | 19.35% |
| 2017 Q2 | 37.01 Million USD | 20.93% |
| 2017 Q3 | 29.54 Million USD | -20.17% |
| 2016 Q2 | 24.36 Million USD | 49.58% |
| 2016 Q4 | 25.64 Million USD | 4.49% |
| 2016 Q1 | 16.28 Million USD | -41.58% |
| 2016 Q3 | 24.54 Million USD | 0.74% |
| 2016 FY | - USD | -15.72% |
| 2015 Q3 | 26.69 Million USD | 4.82% |
| 2015 Q4 | 27.87 Million USD | 4.43% |
| 2015 Q2 | 25.47 Million USD | -8.16% |
| 2015 Q1 | 27.73 Million USD | 14.46% |
| 2015 FY | - USD | 77.83% |
| 2014 Q4 | 24.23 Million USD | 3.28% |
| 2014 Q2 | 21.4 Million USD | 353.41% |
| 2014 FY | - USD | 26.76% |
| 2014 Q3 | 23.46 Million USD | 9.61% |
| 2014 Q1 | -8.44 Million USD | -211.4% |
| 2013 Q2 | 15.95 Million USD | 8.33% |
| 2013 FY | - USD | -50.01% |
| 2013 Q4 | 7.58 Million USD | -34.94% |
| 2013 Q3 | 11.65 Million USD | -26.95% |
| 2013 Q1 | 14.72 Million USD | -32.32% |
| 2012 FY | - USD | 122.26% |
| 2012 Q1 | 22.83 Million USD | -28.65% |
| 2012 Q2 | 25.87 Million USD | 13.34% |
| 2012 Q3 | 25.05 Million USD | -3.17% |
| 2012 Q4 | 21.75 Million USD | -13.16% |
| 2011 Q3 | -547.14 Million USD | -1233.02% |
| 2011 FY | - USD | -285.52% |
| 2011 Q1 | 37.27 Million USD | -23.33% |
| 2011 Q4 | 31.99 Million USD | 105.85% |
| 2011 Q2 | 48.29 Million USD | 29.55% |
| 2010 Q1 | 70.77 Million USD | -3.82% |
| 2010 Q2 | 59.22 Million USD | -16.31% |
| 2010 Q3 | 38.46 Million USD | -35.05% |
| 2010 Q4 | 48.61 Million USD | 26.4% |
| 2010 FY | - USD | -11.49% |
| 2009 FY | - USD | 46.54% |
| 2009 Q4 | 73.58 Million USD | 17.9% |
| 2009 Q3 | 62.4 Million USD | 1.47% |
| 2009 Q2 | 61.5 Million USD | 15.43% |
| 2009 Q1 | 53.28 Million USD | 1.36% |
| 2008 Q3 | 49.7 Million USD | 11.91% |
| 2008 Q4 | 52.56 Million USD | 5.75% |
| 2008 FY | - USD | 67.24% |
| 2008 Q2 | 44.41 Million USD | 37.7% |
| 2008 Q1 | 32.25 Million USD | 6.96% |
| 2007 Q1 | 23.27 Million USD | 6.55% |
| 2007 FY | - USD | 39.98% |
| 2007 Q4 | 30.16 Million USD | 18.55% |
| 2007 Q3 | 25.44 Million USD | -8.73% |
| 2007 Q2 | 27.87 Million USD | 19.74% |
| 2006 Q4 | 21.84 Million USD | 3.94% |
| 2006 Q3 | 21.01 Million USD | 14.22% |
| 2006 Q2 | 18.4 Million USD | 22.74% |
| 2006 Q1 | 14.99 Million USD | 8.9% |
| 2006 FY | - USD | 33.87% |
| 2005 Q2 | 14.26 Million USD | 10.92% |
| 2005 FY | - USD | 51.66% |
| 2005 Q4 | 13.76 Million USD | -14.37% |
| 2005 Q3 | 16.07 Million USD | 12.73% |
| 2005 Q1 | 12.85 Million USD | 16.13% |
| 2004 Q2 | 8.99 Million USD | 15.3% |
| 2004 Q4 | 11.07 Million USD | 14.27% |
| 2004 Q3 | 9.69 Million USD | 7.7% |
| 2004 Q1 | 7.8 Million USD | 20.18% |
| 2004 FY | - USD | 122.02% |
| 2003 Q3 | 3.89 Million USD | 40.85% |
| 2003 Q2 | 2.55 Million USD | 7.04% |
| 2003 FY | - USD | -15.16% |
| 2003 Q1 | 2.18 Million USD | -69.26% |
| 2003 Q4 | 6.5 Million USD | 47.8% |
| 2002 Q3 | 3.09 Million USD | -13.93% |
| 2002 Q2 | 3.74 Million USD | 0.91% |
| 2002 FY | - USD | 87.93% |
| 2002 Q4 | 457 Thousand USD | 200.32% |
| 2002 Q1 | 3.76 Million USD | -10.6% |
| 2001 Q3 | 3.37 Million USD | 34.81% |
| 2001 Q4 | 4.18 Million USD | 22.95% |
| 2001 FY | - USD | 283.52% |
| 2001 Q1 | 3.9 Million USD | 20.02% |
| 2001 Q2 | 2.53 Million USD | -36.86% |
| 2000 FY | - USD | -89.03% |
| 2000 Q4 | 3.3 Million USD | 1578.08% |
| 2000 Q1 | -174 Thousand USD | 84.07% |
| 2000 Q3 | -227 Thousand USD | -682.14% |
| 2000 Q2 | 6000.00 USD | 87.44% |
| 1999 Q3 | 3 Million USD | 276.47% |
| 1999 FY | - USD | 192.12% |
| 1999 Q4 | -1.4 Million USD | -146.67% |
| 1999 Q2 | -1.7 Million USD | -254.91% |
| 1999 Q1 | -365 Thousand USD | 91.11% |
| 1998 Q4 | -5.67 Million USD | 10.17% |
| 1998 Q1 | -3.3 Million USD | -848.28% |
| 1998 FY | - USD | -4300.92% |
| 1998 Q2 | -2.2 Million USD | 33.33% |
| 1998 Q3 | -6 Million USD | -172.73% |
| 1997 Q3 | 100 Thousand USD | 0.0% |
| 1997 FY | - USD | -68.78% |
| 1997 Q4 | -348 Thousand USD | -138.67% |
| 1997 Q1 | 900 Thousand USD | -46.7% |
| 1997 Q2 | 900 Thousand USD | 0.0% |
| 1996 Q2 | 700 Thousand USD | 40.0% |
| 1996 Q3 | 500 Thousand USD | -28.57% |
| 1996 Q4 | 1.68 Million USD | 237.68% |
| 1996 FY | - USD | 16.02% |
| 1996 Q1 | 500 Thousand USD | 25.0% |
| 1995 Q2 | 500 Thousand USD | 66.67% |
| 1995 Q1 | 300 Thousand USD | 101.69% |
| 1995 FY | - USD | 260.0% |
| 1995 Q4 | 400 Thousand USD | 0.0% |
| 1995 Q3 | 400 Thousand USD | -20.0% |
| 1994 FY | - USD | 350.0% |
| 1994 Q4 | -17.8 Million USD | -373.85% |
| 1994 Q1 | 100 Thousand USD | 100.85% |
| 1994 Q2 | 100 Thousand USD | 0.0% |
| 1994 Q3 | 6.5 Million USD | 6400.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q3 | 2.3 Million USD | -51.06% |
| 1993 Q2 | 4.7 Million USD | 2.17% |
| 1993 Q1 | 4.6 Million USD | 0.0% |
| 1993 Q4 | -11.7 Million USD | -608.7% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | -14.7% |
| Addus HomeCare Corporation | 106.55 Million USD | -103.563% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | -666.152% |
| American Oncology Network, Inc. | -39.35 Million USD | 651.226% |
| Astrana Health, Inc. | 123.68 Million USD | -75.371% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | -389.116% |
| IMAC Holdings, Inc. | -5.94 Million USD | 3747.561% |
| biote Corp. | 9.23 Million USD | -2249.069% |
| Cryo-Cell International, Inc. | -10.41 Million USD | 2182.24% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | -67.714% |
| COMPASS Pathways plc | -123.8 Million USD | 275.21% |
| DocGo Inc. | 32.72 Million USD | -562.832% |
| The Ensign Group, Inc. | 353.23 Million USD | 38.593% |
| Healthcare Services Group, Inc. | 75.21 Million USD | -188.402% |
| InnovAge Holding Corp. | 1.15 Million USD | -18696.62% |
| Assure Holdings Corp. | -19.82 Million USD | 1194.194% |
| The Joint Corp. | 9.14 Million USD | -2272.781% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 306.73% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | 1494.52% |
| ModivCare Inc. | -26.75 Million USD | 910.89% |
| NewGenIvf Group Limited | 384.3 Thousand USD | -56342.929% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | 3808.548% |
| Option Care Health, Inc. | 376.79 Million USD | 42.432% |
| P3 Health Partners Inc. | -81.07 Million USD | 367.559% |
| P3 Health Partners Inc. | -81.07 Million USD | 367.559% |
| The Pennant Group, Inc. | 30.36 Million USD | -614.258% |
| Surgery Partners, Inc. | 446.1 Million USD | 51.376% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | 7748.862% |
| Talkspace, Inc. | -22.01 Million USD | 1085.386% |
| Talkspace, Inc. | -22.01 Million USD | 1085.386% |
| The Oncology Institute, Inc. | -70.45 Million USD | 407.879% |
| The Oncology Institute, Inc. | -70.45 Million USD | 407.879% |